Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Endocrinology | Family Medicine
Diabetes Mellitus, Type 1 Clinical Trials
A listing of Diabetes Mellitus, Type 1 medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Arizona
Tucson : University of Arizona Updated
T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
California
Anaheim : Anaheim Clinical Trials (ACT)
Patients with Type I Diabetes needed for a clinical research trial.
Duarte : City of Hope Updated
Detection of Human Beta Cell Death in T1DM Methylation-Specific PCR
Duarte : City of Hope Updated
Long-Term Follow-Up of Islet Transplant Recipients
Duarte : City of Hope Updated
TrialNet TN-01: Trialnet Natural History Study of the Development of Type I Diabetes
Escondido : AMCR Institute, Inc.
A 52- Week Study to Compare the Glycemic Effects, Safety and Tolerability of A 52- Week Study to Evaluate the Safety and Efficacy of CBX129801 in Patients with Type 1 Diabetes With Mild to Moderate Diabetic Peripheral Neuropathy
Escondido : AMCR Institute, Inc.
A Comparison of the Study Medication Once Daily at a Fixed Time to the Study Medication at a Variable Time in Patients With Diabetes Mellitus Type 1
Escondido : AMCR Institute, Inc.
Do you want to try a new glucose meter?
Escondido : AMCR Institute, Inc.
Evaluation of Metabolic Outcomes and Safety of Hylenex Recombinant Used as Pre-administration Infusion Site Treatment in Patients With Diabetes Mellitus Type 1 on Insulin Pump
Escondido : AMCR Institute, Inc.
The Natural History Study of the development of Type 1 Diabetes Screening Blood Test to Identify Increased Risk of Diabetes Mellitus Type 1
Los Angeles : Children’s Hospital of Los Angeles
T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
Sacramento : Sutter Institute for Medical Research (SIMR)
Diabetes Type 1 - Genetics
San Diego : UCSD Rady Children’s Hospital
RETAIN (Part I): A Research Trial of Aralast in New Onset Type 1 Diabetes
View More »
Chula Vista : Profil Institute for Clinical Research, Inc.
A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A
Concord : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
Concord : For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Subjects With Type 1 Diabetes (T1DM)
Encino : For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Subjects With Type 1 Diabetes (T1DM)
Escondido : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
Escondido : For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Subjects With Type 1 Diabetes (T1DM)
Escondido :
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
Fresno : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
Fresno : Research Center of Fresno
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
Fresno :
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
Greenbrae : For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Subjects With Type 1 Diabetes (T1DM)
Irvine :
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
La Jolla : For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Subjects With Type 1 Diabetes (T1DM)
Long Beach : Health Care Partners Medical Group
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
Los Gatos :
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Modesto : Sutter Gold Medical Foundation
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Salinas : Diabetes Care Center
A Study of the Rules for Insulin Dosing in Patients Using Multiple Daily Injections
San Diego : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2605541 Versus Insulin Glargine on Blood Sugar
San Diego : San Diego Clinical Trials
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
San Diego : Accelovance Inc.
Evaluation and Comparison of Noninvasive Blood Glucose Concentrations
San Diego :
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
San Mateo : For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Subjects With Type 1 Diabetes (T1DM)
Stanford : Stanford University and Stanford Hospital & Clinics
Medtronic Treat to Range (TTR) Closed-Loop Control
Torrance :
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
Tustin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
Tustin :
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
Walnut Creek :
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
Colorado
Delaware
Wilmington : Alfred I duPont Hospital
Statins in Children With Type 1 Diabetes and Hypercholesterolemia
District of Columbia
Washington : George Washington University Medical Faculty Associates
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Florida
Miami : University of Miami School of Medicine
T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
Miramar : Comprehensive Clinical Development - Miramar, FL
Overweight Men and Women Including Type 2 Diabetics
West Palm Beach : Metabolic Research Institute, Inc.
Do you have Type 1 Diabetes? Are your blood sugar levels still too high on your current insulin regimen?
View More »
Aventura : Innovative Medical Research of South Florida Inc.
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
DeLand :
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Hialeah : International Research Associates
Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics
Hollywood : For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Subjects With Type 1 Diabetes (T1DM)
Jacksonville : Nemours Children's Clinic
Statins in Children With Type 1 Diabetes and Hypercholesterolemia
Miami : For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Subjects With Type 1 Diabetes (T1DM)
New Port Richey : Suncoast Clinical Research
Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics
Orlando : Orlando Diabetes & Endocrine Specialists, P.A.
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Orlando : Nemours Children's Clinic
Statins in Children With Type 1 Diabetes and Hypercholesterolemia
Palm Harbor : Suncoast Clinical Research
Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics
Pensacola : Nemours Children's Clinic
Statins in Children With Type 1 Diabetes and Hypercholesterolemia
Tallahassee : Tallahassee Endocrine Associates
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Tampa : Diabetes and Hormonal Disease Center
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Georgia
Atlanta : Pinnacle Trials, Inc.
Do you have both Diabetes & Asthma?
Atlanta : Children’s Healthcare of Atlanta at Egleston
RETAIN (Part I): A Research Trial of Aralast in New Onset Type 1 Diabetes
Atlanta : Atlanta Diabetes Associates
RETAIN (Part I): A Research Trial of Aralast in New Onset Type 1 Diabetes
Atlanta : Emory's Children's Center
T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
View More »
Atlanta : For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Subjects With Type 1 Diabetes (T1DM)
Atlanta : Atlanta Diabetes Associates
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Decatur :
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
Roswell : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
Roswell : For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Subjects With Type 1 Diabetes (T1DM)
Idaho
Illinois
Indiana
Indianapolis : Riley Hospital for Children, Indiana University
T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
Iowa
Kansas
Kentucky
Maryland
Baltimore : University of Maryland Medical Center
RETAIN (Part I): A Research Trial of Aralast in New Onset Type 1 Diabetes
Baltimore : University of Maryland Medical Center
T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
View More »
Rockville : For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Subjects With Type 1 Diabetes (T1DM)
Massachusetts
Boston : Massachusetts General Hospital
RETAIN (Part I): A Research Trial of Aralast in New Onset Type 1 Diabetes
Boston : Joslin Diabetes Center
Study to Prevent Kidney Disease in Type 1 Diabetes
Boston : Massachusetts General Hospital
T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
Boston : Joslin Diabetes Center
TrialNet Natural History Study for the Prevention of Type 1 Diabetes
Worcester : UMASS Memorial Medical Center
RETAIN (Part I): A Research Trial of Aralast in New Onset Type 1 Diabetes
View More »
Boston : Massachusettes General Hospital/ Diabetes Research Center
Comparison of Lantus and NPH Insulin in the Dawn Phenomenon
Boston :
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
Michigan
Ann Arbor :
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
Dearborn : Alzohaili Medical Consultants
Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics
Minnesota
Minneapolis : University of Minnesota
T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
View More »
Minneapolis : For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Subjects With Type 1 Diabetes (T1DM)
Missouri
Hazelwood : Healthcare Research Network
Do you have Diabetic Foot Pain? Are you 18+ years old? If so, you may qualify for our study! Call us today to find out more information.
Kansas City : Children’s Mercy Hospital
RETAIN (Part I): A Research Trial of Aralast in New Onset Type 1 Diabetes
Kansas City : The Children’s Mercy Hospital
T1DAL: Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
Kansas City : Dybedal Clinical Research Center
Type 1 Diabetes
St. Louis : Washington University in St. Louis - Center for Clinical Studies
Young Adults Are Needed for a Research Study on Type 1 Diabetes at Washington University.
View More »
St. Louis : Washington University
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Montana
Billings : Billings Clinic Research Center
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
Butte : For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Subjects With Type 1 Diabetes (T1DM)
Nebraska
Omaha : Creighton University
T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
View More »
Omaha :
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
Nevada
Henderson : For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Subjects With Type 1 Diabetes (T1DM)
Las Vegas : For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Subjects With Type 1 Diabetes (T1DM)
Las Vegas : Palm Medical Research Center
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Las Vegas :
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
New Jersey
Hackensack : Advanced Biomedical Research, Inc. (ABR)
Subcutaneous Administration of Lisofylline to Healthy Normal Subjects and Subjects With Type 1 Diabetes
New Mexico
Santa Fe : Soutwest Clinical Research Center, LLC
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
New York
Bronx : Einstein-Montefiore Institute for Clinical & Translational Research
Exenatide (Byetta) vs Pramlintide (Symlin) Role in Post-Prandial Hyperglycemia
Bronx : Einstein-Montefiore Institute for Clinical & Translational Research
New Onset Type 1 Diabetes: Role of Exenatide
Bronx : Biomedical Research Alliance of New York
Type 1 Diabetes- two different insulin treatments.
New York : Naomi Berrie Diabetes Center
Proleukin and Rapamune in Type 1 Diabetes
New York : Naomi Berrie Diabetes Center at Columbia University Medical Center
RETAIN (Part I): A Research Trial of Aralast in New Onset Type 1 Diabetes
New York : Columbia University
The ACCESS Trial for lupus with kidney disease (lupus nephritis)
Rochester : University of Rochester Medical Center, Strong Children’s Research Center
T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
View More »
Bronx : Albert Einstein College of Medicine West Campus CRC
Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting
New Hyde Park : North Shore Diabetes and Endocrine Associates
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
New York : MedHex Health
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
New York :
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
Williamsville : Diabetes-Endocrinology Center of Western NY
Liraglutide in the Treatment of Type 1 Diabetes Mellitus
North Carolina
Durham : University of North Carolina, Diabetes Care Center
T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
View More »
Asheville : For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Subjects With Type 1 Diabetes (T1DM)
Asheville : Mountain Diabetes and Endocrine Center
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Durham : For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Subjects With Type 1 Diabetes (T1DM)
Durham : University of North Carolina Diabetes Care Center
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Morehead City : For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Subjects With Type 1 Diabetes (T1DM)
Ohio
Oklahoma
Oregon
Portland : Research Site
Effect of Different Fixed Pramlintide:Insulin Dose Ratios on Postprandial Glucose in T1DM
Portland : Legacy Clinical Research & Technology Center
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Pennsylvania
Philadelphia : Children’s Hospital of Philadelphia
RETAIN (Part I): A Research Trial of Aralast in New Onset Type 1 Diabetes
Philadelphia : Children’s Hospital of Philadelphia
T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
View More »
Philadelphia : Nemours Children's Clinic-Jefferson
Statins in Children With Type 1 Diabetes and Hypercholesterolemia
South Carolina
Tennessee
Texas
Dallas : University of Texas Southwestern
T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
View More »
Austin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
Austin : For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Subjects With Type 1 Diabetes (T1DM)
Dallas : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
Dallas : For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Subjects With Type 1 Diabetes (T1DM)
Dallas : Diabetech
Diabetes Technology Study of Real-Time Glucose Alerts in the Team Management of Diabetes
Dallas : UT Southwestern Medical Center
Effects of Metreleptin in Type 1 Diabetes Mellitus
Dallas : Research Institute of Dallas
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Dallas :
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
Dallas : Lexicon Investigational Site
Safety and Efficacy of LX4211 in Patients With Inadequately Controlled Type 1 Diabetes Mellitus
Houston :
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
Round Rock : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
Round Rock : For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Subjects With Type 1 Diabetes (T1DM)
San Antonio : For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Subjects With Type 1 Diabetes (T1DM)
San Antonio : Cetero Research
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
San Antonio : SAM Clinical Research Center
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
San Antonio :
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
Utah
Murray : Radiant Research - Salt Lake City
Clinical Research Study for Type 1 Diabetics
Murray : Radiant Research
Diabetes (Type 1) Research Study
Virginia
Charlottesville : University of Virginia
Biobehavioral Mechanisms of Glucose Variability
Charlottesville : University of Virginia Center for Diabetes Technology
Development of an Advisory System for Glycemic Control During the Menstrual Cycle in Patient With Type 1 Diabetes
Charlottesville : University of Virginia
Feasibility Study of Closed Loop Control in Type 1 Diabetes Using Heart Rate Monitoring as an Exercise Marker
Washington
Renton : Rainier Clinical Research Center, Inc.
Do you have Type 1 Diabetes? Rainier Clinical Research Center is seeking participants who have been diagnosed with type 1 diabetes and are interested in participating in a study of a new investigational insulin
Seattle : Benaroya Research Institute at Virginia Mason Research Center
T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
View More »
Olympia : For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Subjects With Type 1 Diabetes (T1DM)
Renton : For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Subjects With Type 1 Diabetes (T1DM)
Seattle : Seattle Children's Hospital
The Effectiveness of Continuous Glucose Monitoring in Diabetes Treatment for Infants and Young Children
Spokane : Northside Internal Medicine Associates, PS
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Tacoma : Chous Eye Care Associates
Diabetes Visual Function Supplement Study
Tacoma : Multicare Specialties Research
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Argentina
San Martin : Hospital Interzonal General de Agudos Eva Perón
Open-label Investigation of the Safety and Efficacy of DIABECELL in Patients With Type 1 Diabetes Mellitus
Australia
Melbourne : St Vincent's Hospital
REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)
Melbourne : Royal Melbourne Hospital
REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)
Perth : University of Western Australia
Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial
Sydney : Royal Prince Albert Hospital
REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)
Austria
Graz :
A Trial Investigating the Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart 15 in Subjects With Type 1 Diabetes
Graz : Medical University of Graz
Short Term Closed-loop Glucose Control in Adults With Type 1 Diabetes
Innsbruck : Universitatsklinik fur Innere Medzin I, Landeskrankenhaus
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Vienna : Rudolfstiftung Hospital
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Belarus
Minsk : Endocrinological Unit 1st City Clinical Hospital
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Minsk : Belarusian Medical Academy of Postgraduate Education
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Minsk : Health Institution City Endocrinological Dispensary
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Minsk : Republican center of Medical Rehabilitation and Balneotherapy
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Mogilov : Health Institution Mogilev Diagnostic Center
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Brazil
Canada
Calgary : LMC Endocrinology Centres
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Calgary :
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
Laval :
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
Montreal :
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
Oakville : LMC Endocrinology Centres
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
View More »
Ontario : St Joseph's Health Care
REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)
Toronto : Hospital for Sick Children
Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial
Toronto : LMC Endocrinoly Centres
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Toronto :
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
China
Beijing : Investigational Site Number 156006
Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.
Beijing : Investigational Site Number 156001
Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.
Beijing : Investigational Site Number 156007
Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.
Changsha : Investigational Site Number 156009
Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.
Guangzhou : Investigational Site Number 156008
Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.
View More »
Hangzhou : Investigational Site Number 156004
Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.
Hangzhou : The First Affiliated Hospital of Zhejiang University
Human Menstrual Blood-derived Mesenchymal Stem Cells Transplantation in Treating Type 1 Diabetic Patients
Jinan : General Hospital of Jinan Military Command
Stem Cell Educator Therapy in Type 1 Diabetes
Shanghai : Investigational Site Number 156016
Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.
Shanghai : Investigational Site Number 156005
Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.
Taiyuan : Investigational Site Number 156019
Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.
Wuhan : Investigational Site Number 156002
Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.
Czech Republic
Prague : IKEM/Diabetes Centre/Videnska
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Prague : Fakultni nemocnice Kralovske Vinohrady - II. internal department
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Denmark
Århus C :
A Trial Investigating the Effect of Acute Hypoglycaemia on Cognitive Function and Brain Activation Patterns in Subjects With Type 1 Diabetes
Gentofte : Steno Diabetes Center
Effect of CSII and CGM on Progression of Late Diabetic Complications
Hillerød : Hillerod Hospital
Recurrent Hypoglycaemia in Type 1 Diabetes
Finland
Oulu : Tutkimusyksikko
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
France
Caen : CHU Côte de Nacre
Obtain a Good Blood Glucose Control With the Paradigm Real Time System
Dommartin les Touls : Hôpital Jeanne D'Arc
Obtain a Good Blood Glucose Control With the Paradigm Real Time System
Lyon : Hôpital Universitaire Debrousse
Obtain a Good Blood Glucose Control With the Paradigm Real Time System
Marseille : Hôpital Sainte Marguerite
Obtain a Good Blood Glucose Control With the Paradigm Real Time System
Montpellier : CH La Peyronie
Obtain a Good Blood Glucose Control With the Paradigm Real Time System
View More »
Paris : Hotel Dieu Hospital
Diagnosis and Physiopathology of Insulin Allergy
Reims : American Memorial Hospital
Obtain a Good Blood Glucose Control With the Paradigm Real Time System
Toulouse : UH Toulouse
Effect of Autonomic Neuropathy on the Efficacy of a DPP-IV Inhibitor (Galvus) Therapy
Toulouse : CHU Rangueil
Obtain a Good Blood Glucose Control With the Paradigm Real Time System
Germany
Dusseldorf : DDZ Studienzentrum Deutsches Diabetes Zentrum
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Giessen : Universitatsklinikum Giessen
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Hannover : Diabetes Centre for Children and Adolescents, Kinderkrankenhaus auf der Bult
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Munchen : Institut für Diabetesforschung an der Klinik und Hochschulambulanz für Kinder- und Jugendmedizin
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Munster : Institut für Diabetesforschung Münster GmbH
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
View More »
Neuss : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2605541 and Glargine and Exercise in Participants With Type 1 Diabetes
Neuss : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2605541 and Glargine in Participants With Type 1 Diabetes
Neuss :
A Trial Investigating the Safety, Tolerability, and Distribution and Activity in the Body of NNC0148-0000-0287 Injected Under the Skin in Healthy Subjects and in Subjects With Type 1 Diabetes
Neuss : Investigational Site Number 276001 Updated
Euglycemic Clamp Study Comparing Two New Insulin Glargine Formulations in Subjects With Type 1 Diabetes Mellitus
Hungary
Szeged : University of Szeged Faculty of Medicin
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Veszprem : Veszprem Megyei Csolnoky Ferenc Korhaz es Rendelointezet Diabetologia Centrum
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Zalaegerszeg : Zala Megyei Korhaz es Rendelointezet Diabetologia Centrum
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
India
Bangalore : Bangalore Diabetes Hospital
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Insulin (IN-105) in Type 1 Diabetes Patients
Bangalore : Diacon Hospital,(Diabetes Care and Research Centre)
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Insulin (IN-105) in Type 1 Diabetes Patients
Karnal : Bharti Research Institute of Diabetes and Endocrinology
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Insulin (IN-105) in Type 1 Diabetes Patients
Israel
Beer Sheva : Soroka University Medical Center
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Beer Sheva : Diabetes Clinic Soroka University
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Beer-Sheva : Soroka University Medical Center
Evaluation of the Performance and Use of Non-Invasive Glucose Monitoring Device
Haifa : Rambam Medical Cent
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Holon : Wolfson Medical Center
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
View More »
Jerusalem : Hadassah Medical Center
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Jerusalem : Hadassah Medical Organization
Measuring and Monitoring Blood Glucose Levels Utilizing Non-invasive Blood Glucose Monitoring Device
Petach Tikva : Schneider Medical Center
Performance Study of the SOLO 2.0 Insulin Pump
Petach-Tiqva : Institute for Endocrinology and Diabetes Schneider Children's MC
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Petah-Tikva : Schneider Children's Medical Center
Long Term Treatment Effect of the Safety, Tolerability and Efficacy of AAT in Type 1 Diabetes
Tel Aviv : Sourasky Medical Center,
Performance Study of the SOLO 2.0 Insulin Pump
Zerifin : Assaf Haroffeh Medical Center
Long Term Treatment Effect of the Safety, Tolerability and Efficacy of AAT in Type 1 Diabetes
Zerifin : Assaf-Harofeh Medical Center
Safety and Tolerability of Oshadi Icp In Patients With Type 1 Diabetes Mellitus - Phase Ib Clinical Study
Italy
Grosseto : P.O. di Grosseto - Stabilimento Misericordia
Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice
Mariano Comense : Az. Osp. S. Anna - Presidio Ospedaliero Cantù - Mariano Comense
Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice
Milan : Istituto Scientifico San Raffaele
Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice
Milan : Ospedale Niguarda Cà Granda
Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice
Milan : Dipartimento di Medicina Interna e Specialistica; IRCCS Ospedale San Raffaele
Study to Assess Efficacy & Safety of Reparixin in Pancreatic Islet Transplantation
View More »
Naples : II Università di Napoli Centro Regionale di Diabetologia Pediatrica "G. Stoppoloni"
Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice
Padua : Università degli Studi di Padova Dipartimento di Medicina Clinica e Sperimentale
Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice
Palermo : . Endocrinologia e Malattie Metaboliche, Dipartimento biomedico di medicina interna e specialistica, Ex Istituto di clinica medica, Università di Palerm
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Pisa : Ospedale Cisanello
Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice
Ravenna : U.O. di Diabetologia, Dip. di Malattie Digestive & Metaboliche
Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice
Rome : University La Sapienza, Policlinico Umberto I
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Rome : Dept. of Endocrinology and Diabetes University Campus Bio-Medico
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Rome : Ospedale Sandro Pertini
Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice
Turin : Azienda Ospedaliera-Universitaria S. Giovanni Battista
Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice
Japan
Kumamoto-Shi : Investigational Site Number 392001
Repeated Dose Study With a New Insulin Glargine Formulation and Lantus® on 24-hour Glucose Profile in Japanese Patients With Type 1 Diabetes Mellitus
Lithuania
Jonava : Private Clinic JSC 'Kristavita'
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Kaunas : Kaunas Medical University Hospital
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Vilnius : Public Institution 'Seskines Outpatient Clinic'
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Vilnius : Vilnius Medical University Hospital, Santariskiu Clinic's
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Netherlands
Amsterdam : VU University Medical Center
The Effects of RT-CGM on Glycemia and QoL in Patients With T1DM and IHA
Maastricht : Maastricht University Medical Centre
REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)
Philippines
Makati City : Beverly Hills Medical Group
Safety and Efficacy of Autologous Adipose-Derived Stem Cell Transplantation in Patients With Type 1 Diabetes
Quezon City : Veterens Memorial Medical Centre
Safety and Efficacy of Autologous Adipose-Derived Stem Cell Transplantation in Patients With Type 1 Diabetes
Poland
Lodz : NZOZ OmniMed
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Puerto Rico
Russian Federation
Chelyabinsk : State Educational Institution for Additional Professional Education (SEIAPE) "Ural State Medical
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Kemerovo : Kemerovo Regional Clinical Hospital
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Moscow : Endocrinological scientific center of Rosmedtechnology
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Moscow : SEIAPE Endocrinology and Diabetology
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Moscow : Clinic of New Medical Technology, LLC
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
View More »
Moscow : City Clinical Hospital #81, Endocrinology Department
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Nizhni Novgorod : State Healthcare Institution (SHI) "Nizhegorodskaya
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Perm : State Healthcare Institution Perm Region Clinical Hospital
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Samara : Limited Liability Company (LLC), Diabetes Center
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
St Petersburg : State Educational Institution of Higher Professional Education
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
St. Petersburg : St. Petersburg State Healthcare Institution
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Tomsk : Siberian State Medical University of Roszdrav
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Spain
Las Palmas de Gran Canaria : Complejo Hospitalario Universitario Insular Materno-Infantil
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Lleida : Hospital Universitari Arnau de Vilanova
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Oviedo : Hospital Universitario Central de Asturias
Stem Cell Educator Therapy in Type 1 Diabetes
Sweden
Switzerland
Basel : University Hospital Basel
Effects of XOMA 052 on Insulin Production in Type 1 Diabetes
United Kingdom
Cambridge : Cambridge University Hospitals NHS Foundation Trust
Short Term Closed-loop Glucose Control in Adults With Type 1 Diabetes
Dundee : Diabetes Support Unit, Ninewells Hospital and Medical School
REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)
Durham : University Hospital North Durham
REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)
Exeter : Peninsula NIHR Clinical Research Facility, Royal Devon and Exeter NHS Foundation Trust
REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)
Glasgow : Stobhill Hospital, Diabetes Clinic
REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)
View More »
High Wycombe : Wycombe Hospital
Comparing Long-acting Insulins During Exercise in Type 1 Diabetes
Hull : Michael White Diabetes Centre, Hull Royal Infirmary
REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)
London : Clinical Investigation Unit, International Centre for Circulatory Health, Imperial College Healthcare NHS Trust
REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)
London : King's College London
Safety and Effectiveness Study of a Closed Loop System Maintaining Patients' Glucose Levels During an Overnight Period
Manchester : Wellcome Trust Clinical Research Facility, Manchester Royal Infirmary
REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)
Newcastle : Newcastle NIHR Clinical Research Facility, Royal Victoria Hospital
REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)
Plymouth : Diabetes Clinical Research Centre, Plymouth
REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)
Salford : Salford Royal NHS Foundation Trust
REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)
Swansea : Clinical Research Unit
Randomized Controlled Trial of Insulin Versus Tablets for Latent Autoimmune Diabetes in Adults (LADA)
